2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
Which Primary Drivers Are Supporting the Continued Market Growth of theBiologics Testing Market?
The swift expansion of both biotechnology and pharmaceutical sectors is anticipated to spur on the growth of the market for testing biologics. The central aim of the pharmaceutical industry is to produce and develop medications targeted at various medical conditions and diseases. In contrast, biotechnology concentrates on applying technology to healthcare and biology. Biologics testing involves carrying out tests to evaluate the immune response to a drug, determine stability, and to identify and quantify impurities. The expansion of the pharmaceutical and biotechnology sectors has triggered advancements in biologics testing technology, such as the creation of novel analytical tools and techniques. This has led to more precise and efficient testing, cutting down both the cost and time needed to introduce new biologics to the market. For instance, Eurostat, the Belgium-based governing entity, reported in July 2024 that there was a noticeable surge in pharmaceutical production in the EU, increasing from €36 billion ($39.4 billion) in 2021, to €44 billion ($46.7 billion) in 2023. Thus, the rapid rise of the biotechnology and pharmaceutical industries contributes significantly to the growth of the biologics testing market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10276&type=smp
#What Growth Opportunities Will Drive the Biologics Testing Market’s CAGR Through 2034?
In recent years, there has been a rapid increase in the size of the biologics testing market. The market, which was worth $5.92 billion in 2024, is expected to expand to $6.85 billion in 2025, indicating a compound annual growth rate (CAGR) of 15.7%. The historic period witnessed this growth due to factors such as the expansion in biologics development, strict regulatory standards, quality control in bioprocessing, increased investments in biopharmaceuticals, and the broadening of biomanufacturing capacity.
In the coming years, the biologics testing market is predicted to experience a significant surge, potentially reaching $12.91 billion by 2029 with a CAGR of 17.2%. The anticipated growth during this period can be credited to the emergence of innovative treatments, the rising need for contract testing services, the broadening of biologics pipelines, the globalization of biopharmaceutical production, and the increased demand for quick testing solutions. Key trends for the forecast period include sophisticated analytical technologies, cell-based assays, next-generation sequencing (NGS), adherence to quality by design (QBD) practices, the incorporation of artificial intelligence (AI), and rapid processes for product launch.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10276
How Are Consumer Market Innovations Shaping the Current and Future Landscape of theBiologics Testing Market?
The emergence of product innovations is a prevailing trend in the biologics testing marketplace. To maintain their market presence, companies in this sector are emphasizing the introduction of new, innovative products. For instance, Charles River Laboratories International, Inc., a non-clinical contract research organization from the US, rolled out the Endosafe Nexus 200 in December 2022. This latest addition to the company’s endotoxin testing series is a fully automated, data integrity compliant instrument, marking the next phase in Charles River’s growth. The Nexus 200 employs Endosafe Limulus Amebocyte Lysate (LAL) cartridge technology and is capable of handling straightforward or complex serial dilutions for water, in-process, and final product evaluations. Functioning on Endosafe EndoScan-V version 6.1, the system enables the export of data to a Laboratory Information Management System (LIMS) interface, offering improved traceability, security, and data management via an integrated touch screen.
Who Are the Key Market Players Influencing the Growth of the Corn and Biologics Testing Industry?
Major companies operating in the biologics testing market include Charles River Laboratories Inc., Thermo Fisher Scientific Inc., Merck KGaA, SGS Société Générale de Surveillance SA, WuXi AppTec Co. Ltd., Sartorius AG, Cytovance Biologics Inc., Pace Analytical Services Inc., Avance Biosciences Inc., Celgene Corporation, Biomerieux SA, Lonza Group Ltd., Genscript Biotech Corp., Bio-Rad Laboratories Inc., Accugen Laboratories Inc., Gibraltar Laboratories Inc., Jordi Labs, Gilead Sciences Inc., Bioquell Limited, Southern Research, Promega Corporation, Lancaster Laboratories Inc., Toxikon Corporation, Eurofins BioPharma Product Testing, Johnson & Johnson Inc., QIAGEN N.V., GlaxoSmithKline plc, Danaher Corporation, Agilent Technologies Inc., PerkinElmer Inc., Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson and Company, Roche Holding AG, Novartis AG, Eli Lilly and Company, Pfizer Inc.
Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report
Which Key Market Segments Comprise the Biologics Testing Market and Drive Its Revenue Growth?
The biologics testing market covered in this report is segmented –
1) By Product: Reagents And Kits, Instruments, Other Products
2) By Test Type: Endotoxin Test, Sterility Test, Mycoplasma Tests, Bioburden Tests, Residual Host-Cell Proteins And DNA Detection Tests, Virus Safety Test, Other Test Types
3) By Application: Vaccine Development And Manufacturing, Monoclonal Antibodies Development And Manufacturing, Cellular And Gene Therapy Products Development And Manufacturing, Blood And Blood Products Development And Manufacturing, Other Applications
Subsegments:
1) By Reagents And Kits: ELISA Kits, PCR Kits, Cell Culture Reagents, Other Assay Kits
2) By Instruments: Spectrophotometers, Chromatography Systems, Microplate Readers, Other Analytical Instruments
3) By Other Products: Software, Consumables, Reference Standards
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=10276&type=smp
Which Regions Are Emerging as Leaders in the Biologics Testing Market?
North America was the largest region in the biologics testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global biologics testing market duirng the forecast period. The regions covered in the biologics testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Reports Similar to the Gobal Biologics Testing Maret 2025, By The Business Research Company:
Tank Wagons Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/tank-wagons-global-market-report
Bag-in-box Containers Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/bag-in-box-containers-global-market-report
Boiler, Tank, And Shipping Container Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
